Protective effect of probiotics in the treatment of infantile eczema

Lin,Rong‑Jun; Qiu,Li‑Hua; Guan,Ren-Zheng; Hu,Su‑Juan; Liu,Ying‑Ying; Wang,Guang‑Jun

doi:10.3892/etm.2015.2299

Protective effect of probiotics in the treatment of infantile eczema

Authors:
- Rong‑Jun Lin
- Li‑Hua Qiu
- Ren-Zheng Guan
- Su‑Juan Hu
- Ying‑Ying Liu
- Guang‑Jun Wang
View Affiliations

Affiliations: Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266071, P.R. China, Department of Pediatrics, The Maternal‑Child Healthcare Center of Qingdao, Qingdao, Shandong 266035, P.R. China, Department of Pediatrics, Shandong Traffic hospital, Jinan, Shandong 250031, P.R. China
Published online on: February 17, 2015 https://doi.org/10.3892/etm.2015.2299
Pages: 1593-1596
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to provide evidence for the application of probiotics in the prevention and treatment of infantile eczema by exploring changes in the intestinal Bifidobacteria levels and the Scoring Atopic Dermatitis (SCORAD) index prior and subsequent to treatment with probiotics in infants with eczema. A total of 40 infants with eczema were randomly divided into treatment and control groups. Prior and subsequent to the treatment, the SCORAD index was evaluated and the content of Bifidobacterium bifidum in the stool of each infant in the two groups was quantified using 16S rRNA/DNA quantitative polymerase chain reaction analysis. After four weeks of treatment with B. bifidum triple viable capsules, the levels of B. bifidum increased sharply (P<0.05) and the SCORAD index was notably reduced (P<0.05) as compared with the values prior to treatment. By contrast, neither the content of B. bifidum nor the SCORAD index changed significantly in the control group after four weeks (P>0.05). Following treatment, the levels of B. bifidum in the stools of the treatment group were significantly higher than those in the stools of the control group (P<0.05), and the SCORAD index was significantly lower than that of the control group (P<0.05). In conclusion, probiotic supplementation has a positive effect on the prevention and treatment of infantile eczema.

View Figures

View References

1	Bieber T: Atopic Dermatitis. Ann Dermatol. 22:125–137. 2010. View Article : Google Scholar : PubMed/NCBI
2	Baron SE, Cohen SN and Archer CB: British Association of Dermatologists and Royal College of General Practitioners: Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 37 (Suppl 1):7–12. 2012. View Article : Google Scholar : PubMed/NCBI
3	Ozdemir O: Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol. 160:295–304. 2010. View Article : Google Scholar : PubMed/NCBI
4	Urisu A, Ebisawa M, Mukoyama T, et al: Japanese guideline for food allergy. Allergol Int. 60:221–236. 2011. View Article : Google Scholar : PubMed/NCBI
5	Jensen MP, Meldrum S, Taylor AL, et al: Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol. 130:1209–1211. 2012. View Article : Google Scholar : PubMed/NCBI
6	Ouwehand AC: Antiallergic effects of probiotics. J Nutr. 137 (3 Suppl 2):794S–797S. 2007.PubMed/NCBI
7	Ozdemir O: Any benefits of probiotics in allergic disorders? Allergy Asthma Proc. 31:103–111. 2010. View Article : Google Scholar : PubMed/NCBI
8	Fiocchi A, Burks W, Bahna SL, et al: WAO Special Committee on Food Allergy and Nutrition: Clinical Use of Probiotics in Pediatric Allergy (cuppa): a world allergy organization position paper. World Allergy Organ J. 5:148–167. 2012. View Article : Google Scholar : PubMed/NCBI
9	Guéniche A, Hennino A, Goujon C, et al: Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur J Dermatol. 16:380–384. 2006.PubMed/NCBI
10	Abrahamsson TR, Jakobsson HE, Andersson AF, et al: Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 129:434–440. 2012. View Article : Google Scholar : PubMed/NCBI
11	Fritsch PO and Reider N: Other eczematous eruptionsDermatology. Bolognila JL, Jorizzo JL and Rapini RP: 2nd. Elsevier; Philadelphia, PA: pp. 201–202. 2008, PubMed/NCBI
12	Garrett JP, Apter AJ, Hoffstad O, et al: Asthma and frequency of wheeze: risk factors for the persistence of atopic dermatitis in children. Ann Allergy Asthma Immunol. 110:146–149. 2013. View Article : Google Scholar : PubMed/NCBI
13	Tang ML: Probiotics and prebiotics: immunological and clinical effects in allergic disease. Nestle Nutr Workshop Ser Pediatr Program. 64:219–238. 2009. View Article : Google Scholar : PubMed/NCBI
14	Kuitunen M, Kukkonen K, Juntunen-Backman K, et al: Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 123:335–341. 2009. View Article : Google Scholar : PubMed/NCBI
15	Yan F and Polk DB: Probiotics and immune health. Curr Opin Gastroenterol. 27:496–501. 2011. View Article : Google Scholar : PubMed/NCBI
16	Fontana L, Bermudez-Brito M, Plaza-Diaz J, et al: Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr. 109 Suppl 2:S35–S50. 2013. View Article : Google Scholar : PubMed/NCBI
17	Rastall RA: Bacteria in the gut: friends and foes and how to alter the balance. J Nutr. 134 (8 Suppl):2022S–2026S. 2004.PubMed/NCBI
18	Hwang JS, Im CR and Im SH: Immune disorders and its correlation with gut microbiome. Immune Netw. 12:129–138. 2012. View Article : Google Scholar : PubMed/NCBI
19	Young SL, Simon MA, Baird MA, et al: Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol. 11:686–890. 2004.PubMed/NCBI
20	Moro G, Arslanoglu S, Stahb B, et al: A mixture of prebiotic oligosaccharides reduces the incidence of atopic dematitis during the first six months of age. Arch Dis Child. 91:814–819. 2006. View Article : Google Scholar : PubMed/NCBI
21	Toh ZQ, Anzela A, Tang ML and Licciardi PV: Probiotic therapy as a novel approach for allergic disease. Front Pharmacol. 3:1712012. View Article : Google Scholar : PubMed/NCBI
22	Gore C, Custovic A, Tannock GW, et al: Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy. 42:112–122. 2012. View Article : Google Scholar : PubMed/NCBI
23	Agarwal R, Sharma N, Chaudhry R, et al: Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr. 36:397–402. 2003. View Article : Google Scholar : PubMed/NCBI
24	Pan SJ, Kuo CH, Lam KP, et al: Probiotics and allergy in children – an update review. Pediatr Allergy Immunol. 21:e659–e666. 2010. View Article : Google Scholar : PubMed/NCBI
25	Food and Agriculture Organization of the United Nations, . World Health Organization; Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria; Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food: Probiotics in Food: Health and Nutritional Properties and Guidelines for Evaluation. FAO/WHO, Rome. 2006.